Cargando...

Immune biomarkers of anti-EGFR monoclonal antibody therapy

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab target the human epidermal growth factor receptor and have been integrated into treatment regimens for advanced squamous cell carcinoma of the head and neck (SCCHN). The therapeutic efficacy of these mAbs has been...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Oncol
Main Authors: Trivedi, S., Concha-Benavente, F., Srivastava, R. M., Jie, H. B., Gibson, S. P., Schmitt, N. C., Ferris, R. L.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269339/
https://ncbi.nlm.nih.gov/pubmed/24997207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdu156
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!